ReviewPharmacology & therapeutics2016

Targeting the ROS-HIF-1-endothelin axis as a therapeutic approach for the treatment of obstructive sleep apnea-related cardiovascular complications.

Elise Belaidi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.